KetamineNebulized Ketamine for the Treatment of Major Depressive Disorder

Sponsor:

Theresa Jacob, PhD, MPH

Code:

NCT06752759

Conditions

Severe Depression

Moderate Depression

Ketamine

Midazolam

Peripheral Nervous System Agents

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

nebulized ketamine

nebulized midazolam

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Theresa Jacob, PhD, MPH on 2026-04-24.